A new company is responsible for Japanese promotional activities for Actair, Stallergenes Greer’s sublingual immunotherapy ...

Stallergenes Greer, Shionogi & Co., Ltd. ("Shionogi") and CEOLIA Pharma Co. Ltd ("CEOLIA") today announced the transition of promotional activities for Actair® in Japan. Actair® is Stallergenes ...

Adult and Pediatric Clinical Trials of Sublingual Immunotherapy in the USA Dai Park; Nora Daher; Michael S Blaiss Disclosures Expert Rev Clin Immunol. 2012;8 (6):557-564.

Sublingual immunotherapy (SLIT) appears to be associated with a lower incidence of systemic reactions. The clinical efficacy of subcutaneous immunotherapy (SCIT) is well established for both ...

Immunotherapy. 2011;3 (6):747-756. 0 Oral Mucosal Immune Responses It is postulated that Langerhans-like local DCs are most likely to be critically involved in the persistence of allergen in the ...

Two recent meta-analyses in children showed that sublingual delivery of allergen vaccination constitutes a safe and effective alternative to the injectable route to reduce allergic respiratory ...

The global allergy immunotherapy market is projected to grow from USD 3.7 billion in 2025 to USD 5 billion by 2035, registering a CAGR of 3.5%, according to Future Market Insights on 22 May 2025. This ...

Key therapies in the birch allergy market include antihistamines, corticosteroids, and allergen immunotherapy, with subcutaneous and sublingual immunotherapy gaining traction due to their ...

The global birch allergy market is experiencing robust growth due to increasing cases of allergic rhinitis from birch pollen and advancements in treatments like immunotherapy. Rising awareness and ...